Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine ...

"We are excited to provide an updated assessment of objective response to dordaviprone previously reported in the blinded independent central review (BICR) cohort 1 in recurrent H3 K27M-mutant diffuse ...

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Nine-month Results Remain On Track for Net ProfitAd Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, November 11, 2024-Addex ...

Six years after the deadly Camp Fire tore through Butte County and nearly destroyed the town of Paradise. Itwas the deadliest ...

Celebrities and influencers have been endorsing the scan all over social media, but it comes with a wild price tag.

Liyanage Amarakeerthi Professor of Sinhala, University of Peradeniya  (Keynote speech delivered at the International ...

Lexeo Therapeutics said Wednesday that it received positive data for its Alzheimer's disease treatment, which suggests that higher doses improved results. The clinical-stage genetic medicine company ...

Biogen partners with Neomorph to develop molecular glue degraders for Alzheimer's and other diseases, offering up to $1.45B in payments.

Summary: A recent study highlights that many autistic children show an intense interest in letters and numbers, which may play a distinct role in their language development. By analyzing clinical ...

A team of researchers led by the Department of Neurology with Clinical Neurophysiology ... the Paced Auditory Serial Addition Task, the Symbol Digit Modalities Test, and the Multiple Sclerosis ...

Neurological disorders are disorders that affect the central nervous system or the peripheral nervous systems and can impair the brain, spinal cord, peripheral nerve or neuromuscular function. A ...